Back

Organ Transplant System Sees Reforms and New Safeguards

At a glance

  • Over 100,000 people were on the U.S. transplant waiting list as of May 2025
  • HRSA launched a dashboard in August 2025 to track allocation deviations
  • Total organ transplants in 2025 exceeded 49,000 nationwide

The U.S. organ transplant system is undergoing reforms as federal agencies introduce new monitoring tools and develop additional safeguards. These changes follow recent reports and updated data on transplant allocation and outcomes.

As of May 2025, the national waiting list for organ transplants included more than 100,000 individuals, according to the U.S. Government Accountability Office. The Organ Procurement and Transplantation Network (OPTN), established in 1984, manages this list and oversees allocation procedures, with the United Network for Organ Sharing (UNOS) operating the network under the Department of Health and Human Services since 1986.

In August 2025, the Health Resources and Services Administration (HRSA) introduced a public dashboard to track instances where organ allocation did not follow the standard match order, known as “allocation out of sequence.” This tool was designed to provide greater transparency regarding deviations from established allocation protocols.

Recent federal data indicate that the rate of patients being skipped for transplants has dropped by more than half in recent months. This reduction follows increased oversight and the implementation of new monitoring measures.

What the numbers show

  • In 2024, there were 41,119 organ transplants from deceased donors in the U.S
  • Total organ transplants rose to just over 49,000 in 2025, up from 48,150 in 2024
  • Federal data showed 116 fewer deceased-donor kidney transplants in 2025 compared to 2024

Despite the decrease in deceased-donor kidney transplants in 2025, the overall number of organ transplants increased slightly. This trend reflects ongoing adjustments in the allocation process and efforts to improve system efficiency.

Reports have surfaced of rare cases in which patients were being prepared for organ retrieval while showing signs of life. In each reported instance, the procedures were stopped before proceeding further.

Following these reports, new safeguards are being developed to prevent similar incidents in the future. These measures are part of a broader effort to enhance patient safety and maintain public trust in the transplant system.

The combination of increased transparency, new monitoring tools, and the development of additional safeguards represents a continued evolution in how the U.S. manages organ allocation and transplant procedures. Federal agencies remain focused on addressing challenges and improving outcomes for those awaiting transplants.

* This article is based on publicly available information at the time of writing.

Related Articles

  1. The US signed health agreements with nine African nations, cutting aid by 49% and increasing local funding, according to reports.

  2. Gynaecology waiting lists in Northern Ireland surpass 50,700, revealing significant strain on the healthcare system.

  3. A new study on cellphone radiation and health has been launched, according to the regulator. The FDA has removed previous safety claims.

  4. Aimee Donnellan's book explores GLP-1 drugs for obesity treatment, with the market projected to reach USD 62.8 billion by 2024, according to reports.

  5. A study identifies 21 genomic regions associated with bowel movement frequency and highlights vitamin B1's role, according to researchers.

More on Health

  1. In 2024, 21.8% of US adults reported no physical activity outside work, with Mississippi at 30.6% and Colorado at 15.6%, according to a health report.

  2. A suspension of a US-funded hepatitis B vaccine study has been announced for an ethics review, according to health officials.

  3. NHS England is launching a genetic cancer risk register for 120 genes to enhance early detection and tailored care, according to official sources.

  4. Recent studies show bupivacaine and rimegepant reduced tumor growth and pain in mouse models of bone cancer, according to research findings.

  5. A Treponema pallidum genome from a 5,500-year-old skeleton was analyzed. This discovery significantly extends the bacterium's genetic timeline.